Table 4.
N Patients | N Events | Median survival (months) | Lower 95% CI | Upper 95% CI | P | |
---|---|---|---|---|---|---|
All | 115 | 94 | 7.2 | 5.7 | 9.4 | |
Age | ||||||
< 50 | 65 | 54 | 8.5 | 6.6 | 11.3 | |
≥ 50 | 50 | 40 | 5.5 | 3.5 | 9.4 | .11 |
Menopausal Status | ||||||
Pre | 53 | 44 | 9.8 | 6.6 | 11.9 | |
Post | 62 | 50 | 5.8 | 3.7 | 8.9 | .13 |
Race | ||||||
White | 82 | 69 | 8.9 | 5.8 | 10.8 | |
Black | 15 | 11 | 7.7 | 4.1 | 8.1 | |
Other | 18 | 14 | 5.5 | 2.8 | 19.8 | .97 |
Stage | ||||||
I | 16 | 13 | 7.7 | 5.7 | 18.4 | |
II | 51 | 42 | 9.8 | 5.5 | 11.6 | |
III | 48 | 39 | 5.8 | 3.4 | 6.9 | .61 |
Nuclear Grade | ||||||
II | 6 | 5 | 20.5 | 3.1 | 30.5 | |
III | 107 | 88 | 6.9 | 5.7 | 9.4 | .32 |
Lymphovascular invasion | ||||||
Negative | 66 | 54 | 8.1 | 5.8 | 11.0 | |
Positive | 46 | 38 | 6.4 | 4.2 | 9.7 | .20 |
Breast surgery | ||||||
Breast conservation | 42 | 32 | 7.7 | 4.6 | 10.8 | |
Mastectomy | 68 | 59 | 6.9 | 5.4 | 9.7 | .63 |
Adjuvant chemotherapy | ||||||
No | 64 | 49 | 5.8 | 3.7 | 8.2 | |
Yes | 51 | 45 | 8.9 | 6.9 | 11.9 | .57 |
Taxane | ||||||
No | 32 | 25 | 10.4 | 7.7 | 20.5 | |
Yes | 83 | 69 | 6.4 | 4.1 | 8.5 | .051 |
Anthracycline | ||||||
No | 20 | 14 | 10.4 | 6.9 | 26.3 | |
Yes | 95 | 80 | 6.5 | 4.6 | 8.5 | .14 |
Adjuvant radiation | ||||||
No | 38 | 35 | 6.7 | 3.2 | 11.0 | |
Yes | 77 | 59 | 7.7 | 5.8 | 9.8 | .61 |